Last updated on April 24, 2014 at 17:35 EDT

Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 – 2017)

June 28, 2013

DUBLIN, June 28, 2013 /PRNewswire/ –

Research and Markets ( http://www.researchandmarkets.com/research/42wzs7/global)
has announced the addition of the “Global Transfection (Gene Delivery, DNA Delivery,
Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate,
Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)”
[http://www.researchandmarkets.com/research/42wzs7/global ] report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769 )

Transfection is an enabler technology used for many cell based research activities
with applications spanning production of recombinant proteins and recombinant cell lines,
gene therapy, delivery of therapeutics and also drug discovery. This research report
provides a brief description on transfection technologies, its evolution, comparative
analysis, market landscape analysis, competitive scenario and emerging technology and
application trends. Global research and development Network, Innovation and Spin offs have
been discussed. The report tracks regional adoption and development trends, providing
strategic recommendation to stay active and compete in the market space. An impact
analysis of major drivers and restraints influencing the growth of the market is mapped
for five year period.

Key Driver:

Advances in cell research and therapeutic delivery

Cell research is a major driving factor for transfection market, as more than 60% of
the users are of academic institutions and researchers. Research in gene transfer is being
performed in in vivo conditions for different therapeutic applications; there is a growing
demand for new transfection technologies to address unmet needs for therapeutic delivery
which is driving the transfection market.

Key Restraint:

Home brew Reagents restricts sale of commercial kits

Home brew reagents are still the preferred choice of reagents for transfection by
researchers all over the world. Most of the researchers prepare their own reagents from
their laboratory to conduct their research. This is true for most of the reagent based
transfection reactions. This allows them to reduce cost involved in purchasing commercial

Key Challenge:

New disruptive technologies required to address transfection in hard-to-transfect

Transfection [http://www.researchandmarkets.com/research/42wzs7/global ] is an enabler
technology which is used in many cell research activities, however only few cell lines are
majorly used in these experiments restricting the scope of the study. Transfection in hard
to transfect cells is the need of hour and it is a major challenge. There are few upcoming
transfection technologies like nucleofection and magnetofection – which are an off-shoot
of electroporation, which have the potential to address these challenges but are currently
cost prohibitive due to which the technologies may have a much slower uptake in the
developing world.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Transfection Technologies – Technology Landscape Analysis

4. Transfection – Market Landscape Analysis

5. Global R&D Portfolio Analysis

6. Investment/Funding Analysis

7. Transfection – Diffusion Analysis

8. Competitive Landscape

9. Opportunity Evaluation And Technology Benchmarking/Roadmapping

10. Patent Analysis

11. Analyst Insights And Recommendations

12. Company Profiles

Companies Mentioned

– Life Technologies Corporation
- Lonza Group Ltd.
- Promega Corporation
- Sigma Aldrich Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Roche Applied Science
- Qiagen N.V.,
- Inovio Pharmaceuticals Inc.,
- Polyplus Transfection S.A.
- Mirus Bio Llc.
- Clonetech Laboratories, Inc.
- Signagen Laboratories
- Maxcyte, Inc.
- Nanotherics
- Genlantis
- Techulon Inc.,
- Deliverics Ltd.
- Oz Biosciences
- Molecular Transfer Inc.,
- Altogen Biosystems
- Promokine Gmbh

For more information visit


        Research and Markets
        Laura Wood, Senior Manager.
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +353-1-481-1716

Sector: Biotechnology
[http://www.researchandmarkets.com/categories.asp?cat_id=1&campaign_id=42wzs7 ]



SOURCE Research and Markets

Source: PR Newswire